0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Contract Pharmaceutical Manufacturing Market Research Report 2026
Published Date: 2026-02-03
|
Report Code: QYRE-Auto-34T8825
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Contract Pharmaceutical Manufacturing Market Size Status and Forecast 2022
BUY CHAPTERS

Global Contract Pharmaceutical Manufacturing Market Research Report 2026

Code: QYRE-Auto-34T8825
Report
2026-02-03
Pages:131
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Contract Pharmaceutical Manufacturing Market Size

The global Contract Pharmaceutical Manufacturing market was valued at US$ 103070 million in 2025 and is anticipated to reach US$ 153110 million by 2032, at a CAGR of 5.9% from 2026 to 2032.

Contract Pharmaceutical Manufacturing Market

Contract Pharmaceutical Manufacturing Market

Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
Global Contract Pharmaceutical Manufacturing key players include Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, etc. Global top five players hold a share about 10%.
North America is the largest market, with a share about 30%, followed by Europe and China, having a total share about 30 percent.
In terms of product, API is the largest segment, with a share about 75%. And in terms of application, the largest application is Large Enterprise, followed by Small Medium Enterprise.
This report delivers a comprehensive overview of the global Contract Pharmaceutical Manufacturing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Contract Pharmaceutical Manufacturing. The Contract Pharmaceutical Manufacturing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Contract Pharmaceutical Manufacturing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Contract Pharmaceutical Manufacturing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Contract Pharmaceutical Manufacturing Market Report

Report Metric Details
Report Name Contract Pharmaceutical Manufacturing Market
Accounted market size in 2025 US$ 103070 million
Forecasted market size in 2032 US$ 153110 million
CAGR 5.9%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Oral
  • Injectable
  • API
  • Other
Segment by Application
  • Large Enterprise
  • Small Medium Enterprise
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Catalent, DPx, Lonza, Piramal Healthcare, Aenova, Jubilant, Famar, Boehringer Ingelheim, Fareva Holding, AbbVie, Nipro Corp, Vetter, Sopharma, DPT Laboratories, Recipharm, NextPharma, Dishman, Aesica
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Contract Pharmaceutical Manufacturing companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Contract Pharmaceutical Manufacturing Market growing?

Ans: The Contract Pharmaceutical Manufacturing Market witnessing a CAGR of 5.9% during the forecast period 2026-2032.

What is the Contract Pharmaceutical Manufacturing Market size in 2032?

Ans: The Contract Pharmaceutical Manufacturing Market size in 2032 will be US$ 153110 million.

What is the market share of major companies in Contract Pharmaceutical Manufacturing Market?

Ans: Global top five players hold a share about 10%.

What is the Contract Pharmaceutical Manufacturing Market share by type?

Ans: In terms of product, API is the largest segment, with a share about 75%.

Who are the main players in the Contract Pharmaceutical Manufacturing Market report?

Ans: The main players in the Contract Pharmaceutical Manufacturing Market are Catalent, DPx, Lonza, Piramal Healthcare, Aenova, Jubilant, Famar, Boehringer Ingelheim, Fareva Holding, AbbVie, Nipro Corp, Vetter, Sopharma, DPT Laboratories, Recipharm, NextPharma, Dishman, Aesica

What are the Application segmentation covered in the Contract Pharmaceutical Manufacturing Market report?

Ans: The Applications covered in the Contract Pharmaceutical Manufacturing Market report are Large Enterprise, Small Medium Enterprise

What are the Type segmentation covered in the Contract Pharmaceutical Manufacturing Market report?

Ans: The Types covered in the Contract Pharmaceutical Manufacturing Market report are Oral, Injectable, API, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Oral
1.2.3 Injectable
1.2.4 API
1.2.5 Other
1.3 Market by Application
1.3.1 Global Contract Pharmaceutical Manufacturing Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Large Enterprise
1.3.3 Small Medium Enterprise
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Contract Pharmaceutical Manufacturing Market Perspective (2021–2032)
2.2 Global Contract Pharmaceutical Manufacturing Growth Trends by Region
2.2.1 Global Contract Pharmaceutical Manufacturing Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Contract Pharmaceutical Manufacturing Historic Market Size by Region (2021–2026)
2.2.3 Contract Pharmaceutical Manufacturing Forecasted Market Size by Region (2027–2032)
2.3 Contract Pharmaceutical Manufacturing Market Dynamics
2.3.1 Contract Pharmaceutical Manufacturing Industry Trends
2.3.2 Contract Pharmaceutical Manufacturing Market Drivers
2.3.3 Contract Pharmaceutical Manufacturing Market Challenges
2.3.4 Contract Pharmaceutical Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Contract Pharmaceutical Manufacturing Players by Revenue
3.1.1 Global Top Contract Pharmaceutical Manufacturing Players by Revenue (2021–2026)
3.1.2 Global Contract Pharmaceutical Manufacturing Revenue Market Share by Players (2021–2026)
3.2 Global Top Contract Pharmaceutical Manufacturing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Contract Pharmaceutical Manufacturing Revenue
3.4 Global Contract Pharmaceutical Manufacturing Market Concentration Ratio
3.4.1 Global Contract Pharmaceutical Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Contract Pharmaceutical Manufacturing Revenue in 2025
3.5 Global Key Players of Contract Pharmaceutical Manufacturing Head Offices and Areas Served
3.6 Global Key Players of Contract Pharmaceutical Manufacturing, Products and Applications
3.7 Global Key Players of Contract Pharmaceutical Manufacturing, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Contract Pharmaceutical Manufacturing Breakdown Data by Type
4.1 Global Contract Pharmaceutical Manufacturing Historic Market Size by Type (2021–2026)
4.2 Global Contract Pharmaceutical Manufacturing Forecasted Market Size by Type (2027–2032)
5 Contract Pharmaceutical Manufacturing Breakdown Data by Application
5.1 Global Contract Pharmaceutical Manufacturing Historic Market Size by Application (2021–2026)
5.2 Global Contract Pharmaceutical Manufacturing Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Contract Pharmaceutical Manufacturing Market Size (2021–2032)
6.2 North America Contract Pharmaceutical Manufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Contract Pharmaceutical Manufacturing Market Size by Country (2021–2026)
6.4 North America Contract Pharmaceutical Manufacturing Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Contract Pharmaceutical Manufacturing Market Size (2021–2032)
7.2 Europe Contract Pharmaceutical Manufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Contract Pharmaceutical Manufacturing Market Size by Country (2021–2026)
7.4 Europe Contract Pharmaceutical Manufacturing Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Contract Pharmaceutical Manufacturing Market Size (2021–2032)
8.2 Asia-Pacific Contract Pharmaceutical Manufacturing Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Contract Pharmaceutical Manufacturing Market Size by Region (2021–2026)
8.4 Asia-Pacific Contract Pharmaceutical Manufacturing Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Contract Pharmaceutical Manufacturing Market Size (2021–2032)
9.2 Latin America Contract Pharmaceutical Manufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Contract Pharmaceutical Manufacturing Market Size by Country (2021–2026)
9.4 Latin America Contract Pharmaceutical Manufacturing Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Contract Pharmaceutical Manufacturing Market Size (2021–2032)
10.2 Middle East & Africa Contract Pharmaceutical Manufacturing Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Country (2021–2026)
10.4 Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Details
11.1.2 Catalent Business Overview
11.1.3 Catalent Contract Pharmaceutical Manufacturing Introduction
11.1.4 Catalent Revenue in Contract Pharmaceutical Manufacturing Business (2021–2026)
11.1.5 Catalent Recent Development
11.2 DPx
11.2.1 DPx Company Details
11.2.2 DPx Business Overview
11.2.3 DPx Contract Pharmaceutical Manufacturing Introduction
11.2.4 DPx Revenue in Contract Pharmaceutical Manufacturing Business (2021–2026)
11.2.5 DPx Recent Development
11.3 Lonza
11.3.1 Lonza Company Details
11.3.2 Lonza Business Overview
11.3.3 Lonza Contract Pharmaceutical Manufacturing Introduction
11.3.4 Lonza Revenue in Contract Pharmaceutical Manufacturing Business (2021–2026)
11.3.5 Lonza Recent Development
11.4 Piramal Healthcare
11.4.1 Piramal Healthcare Company Details
11.4.2 Piramal Healthcare Business Overview
11.4.3 Piramal Healthcare Contract Pharmaceutical Manufacturing Introduction
11.4.4 Piramal Healthcare Revenue in Contract Pharmaceutical Manufacturing Business (2021–2026)
11.4.5 Piramal Healthcare Recent Development
11.5 Aenova
11.5.1 Aenova Company Details
11.5.2 Aenova Business Overview
11.5.3 Aenova Contract Pharmaceutical Manufacturing Introduction
11.5.4 Aenova Revenue in Contract Pharmaceutical Manufacturing Business (2021–2026)
11.5.5 Aenova Recent Development
11.6 Jubilant
11.6.1 Jubilant Company Details
11.6.2 Jubilant Business Overview
11.6.3 Jubilant Contract Pharmaceutical Manufacturing Introduction
11.6.4 Jubilant Revenue in Contract Pharmaceutical Manufacturing Business (2021–2026)
11.6.5 Jubilant Recent Development
11.7 Famar
11.7.1 Famar Company Details
11.7.2 Famar Business Overview
11.7.3 Famar Contract Pharmaceutical Manufacturing Introduction
11.7.4 Famar Revenue in Contract Pharmaceutical Manufacturing Business (2021–2026)
11.7.5 Famar Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Details
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Introduction
11.8.4 Boehringer Ingelheim Revenue in Contract Pharmaceutical Manufacturing Business (2021–2026)
11.8.5 Boehringer Ingelheim Recent Development
11.9 Fareva Holding
11.9.1 Fareva Holding Company Details
11.9.2 Fareva Holding Business Overview
11.9.3 Fareva Holding Contract Pharmaceutical Manufacturing Introduction
11.9.4 Fareva Holding Revenue in Contract Pharmaceutical Manufacturing Business (2021–2026)
11.9.5 Fareva Holding Recent Development
11.10 AbbVie
11.10.1 AbbVie Company Details
11.10.2 AbbVie Business Overview
11.10.3 AbbVie Contract Pharmaceutical Manufacturing Introduction
11.10.4 AbbVie Revenue in Contract Pharmaceutical Manufacturing Business (2021–2026)
11.10.5 AbbVie Recent Development
11.11 Nipro Corp
11.11.1 Nipro Corp Company Details
11.11.2 Nipro Corp Business Overview
11.11.3 Nipro Corp Contract Pharmaceutical Manufacturing Introduction
11.11.4 Nipro Corp Revenue in Contract Pharmaceutical Manufacturing Business (2021–2026)
11.11.5 Nipro Corp Recent Development
11.12 Vetter
11.12.1 Vetter Company Details
11.12.2 Vetter Business Overview
11.12.3 Vetter Contract Pharmaceutical Manufacturing Introduction
11.12.4 Vetter Revenue in Contract Pharmaceutical Manufacturing Business (2021–2026)
11.12.5 Vetter Recent Development
11.13 Sopharma
11.13.1 Sopharma Company Details
11.13.2 Sopharma Business Overview
11.13.3 Sopharma Contract Pharmaceutical Manufacturing Introduction
11.13.4 Sopharma Revenue in Contract Pharmaceutical Manufacturing Business (2021–2026)
11.13.5 Sopharma Recent Development
11.14 DPT Laboratories
11.14.1 DPT Laboratories Company Details
11.14.2 DPT Laboratories Business Overview
11.14.3 DPT Laboratories Contract Pharmaceutical Manufacturing Introduction
11.14.4 DPT Laboratories Revenue in Contract Pharmaceutical Manufacturing Business (2021–2026)
11.14.5 DPT Laboratories Recent Development
11.15 Recipharm
11.15.1 Recipharm Company Details
11.15.2 Recipharm Business Overview
11.15.3 Recipharm Contract Pharmaceutical Manufacturing Introduction
11.15.4 Recipharm Revenue in Contract Pharmaceutical Manufacturing Business (2021–2026)
11.15.5 Recipharm Recent Development
11.16 NextPharma
11.16.1 NextPharma Company Details
11.16.2 NextPharma Business Overview
11.16.3 NextPharma Contract Pharmaceutical Manufacturing Introduction
11.16.4 NextPharma Revenue in Contract Pharmaceutical Manufacturing Business (2021–2026)
11.16.5 NextPharma Recent Development
11.17 Dishman
11.17.1 Dishman Company Details
11.17.2 Dishman Business Overview
11.17.3 Dishman Contract Pharmaceutical Manufacturing Introduction
11.17.4 Dishman Revenue in Contract Pharmaceutical Manufacturing Business (2021–2026)
11.17.5 Dishman Recent Development
11.18 Aesica
11.18.1 Aesica Company Details
11.18.2 Aesica Business Overview
11.18.3 Aesica Contract Pharmaceutical Manufacturing Introduction
11.18.4 Aesica Revenue in Contract Pharmaceutical Manufacturing Business (2021–2026)
11.18.5 Aesica Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Oral
 Table 3. Key Players of Injectable
 Table 4. Key Players of API
 Table 5. Key Players of Other
 Table 6. Global Contract Pharmaceutical Manufacturing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Contract Pharmaceutical Manufacturing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Contract Pharmaceutical Manufacturing Market Size by Region (US$ Million), 2021–2026
 Table 9. Global Contract Pharmaceutical Manufacturing Market Share by Region (2021–2026)
 Table 10. Global Contract Pharmaceutical Manufacturing Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 11. Global Contract Pharmaceutical Manufacturing Market Share by Region (2027–2032)
 Table 12. Contract Pharmaceutical Manufacturing Market Trends
 Table 13. Contract Pharmaceutical Manufacturing Market Drivers
 Table 14. Contract Pharmaceutical Manufacturing Market Challenges
 Table 15. Contract Pharmaceutical Manufacturing Market Restraints
 Table 16. Global Contract Pharmaceutical Manufacturing Revenue by Players (US$ Million), 2021–2026
 Table 17. Global Contract Pharmaceutical Manufacturing Market Share by Players (2021–2026)
 Table 18. Global Top Contract Pharmaceutical Manufacturing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Contract Pharmaceutical Manufacturing Revenue, 2025
 Table 19. Ranking of Global Top Contract Pharmaceutical Manufacturing Companies by Revenue (US$ Million) in 2025
 Table 20. Global 5 Largest Players Market Share by Contract Pharmaceutical Manufacturing Revenue (CR5 and HHI), 2021–2026
 Table 21. Global Key Players of Contract Pharmaceutical Manufacturing, Headquarters and Area Served
 Table 22. Global Key Players of Contract Pharmaceutical Manufacturing, Products and Applications
 Table 23. Global Key Players of Contract Pharmaceutical Manufacturing, Date of General Availability (GA)
 Table 24. Mergers and Acquisitions, Expansion Plans
 Table 25. Global Contract Pharmaceutical Manufacturing Market Size by Type (US$ Million), 2021–2026
 Table 26. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2021–2026)
 Table 27. Global Contract Pharmaceutical Manufacturing Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 28. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2027–2032)
 Table 29. Global Contract Pharmaceutical Manufacturing Market Size by Application (US$ Million), 2021–2026
 Table 30. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2021–2026)
 Table 31. Global Contract Pharmaceutical Manufacturing Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 32. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2027–2032)
 Table 33. North America Contract Pharmaceutical Manufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 34. North America Contract Pharmaceutical Manufacturing Market Size by Country (US$ Million), 2021–2026
 Table 35. North America Contract Pharmaceutical Manufacturing Market Size by Country (US$ Million), 2027–2032
 Table 36. Europe Contract Pharmaceutical Manufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. Europe Contract Pharmaceutical Manufacturing Market Size by Country (US$ Million), 2021–2026
 Table 38. Europe Contract Pharmaceutical Manufacturing Market Size by Country (US$ Million), 2027–2032
 Table 39. Asia-Pacific Contract Pharmaceutical Manufacturing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Asia-Pacific Contract Pharmaceutical Manufacturing Market Size by Region (US$ Million), 2021–2026
 Table 41. Asia-Pacific Contract Pharmaceutical Manufacturing Market Size by Region (US$ Million), 2027–2032
 Table 42. Latin America Contract Pharmaceutical Manufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Latin America Contract Pharmaceutical Manufacturing Market Size by Country (US$ Million), 2021–2026
 Table 44. Latin America Contract Pharmaceutical Manufacturing Market Size by Country (US$ Million), 2027–2032
 Table 45. Middle East & Africa Contract Pharmaceutical Manufacturing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Country (US$ Million), 2021–2026
 Table 47. Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Country (US$ Million), 2027–2032
 Table 48. Catalent Company Details
 Table 49. Catalent Business Overview
 Table 50. Catalent Contract Pharmaceutical Manufacturing Product
 Table 51. Catalent Revenue in Contract Pharmaceutical Manufacturing Business (US$ Million), 2021–2026
 Table 52. Catalent Recent Development
 Table 53. DPx Company Details
 Table 54. DPx Business Overview
 Table 55. DPx Contract Pharmaceutical Manufacturing Product
 Table 56. DPx Revenue in Contract Pharmaceutical Manufacturing Business (US$ Million), 2021–2026
 Table 57. DPx Recent Development
 Table 58. Lonza Company Details
 Table 59. Lonza Business Overview
 Table 60. Lonza Contract Pharmaceutical Manufacturing Product
 Table 61. Lonza Revenue in Contract Pharmaceutical Manufacturing Business (US$ Million), 2021–2026
 Table 62. Lonza Recent Development
 Table 63. Piramal Healthcare Company Details
 Table 64. Piramal Healthcare Business Overview
 Table 65. Piramal Healthcare Contract Pharmaceutical Manufacturing Product
 Table 66. Piramal Healthcare Revenue in Contract Pharmaceutical Manufacturing Business (US$ Million), 2021–2026
 Table 67. Piramal Healthcare Recent Development
 Table 68. Aenova Company Details
 Table 69. Aenova Business Overview
 Table 70. Aenova Contract Pharmaceutical Manufacturing Product
 Table 71. Aenova Revenue in Contract Pharmaceutical Manufacturing Business (US$ Million), 2021–2026
 Table 72. Aenova Recent Development
 Table 73. Jubilant Company Details
 Table 74. Jubilant Business Overview
 Table 75. Jubilant Contract Pharmaceutical Manufacturing Product
 Table 76. Jubilant Revenue in Contract Pharmaceutical Manufacturing Business (US$ Million), 2021–2026
 Table 77. Jubilant Recent Development
 Table 78. Famar Company Details
 Table 79. Famar Business Overview
 Table 80. Famar Contract Pharmaceutical Manufacturing Product
 Table 81. Famar Revenue in Contract Pharmaceutical Manufacturing Business (US$ Million), 2021–2026
 Table 82. Famar Recent Development
 Table 83. Boehringer Ingelheim Company Details
 Table 84. Boehringer Ingelheim Business Overview
 Table 85. Boehringer Ingelheim Contract Pharmaceutical Manufacturing Product
 Table 86. Boehringer Ingelheim Revenue in Contract Pharmaceutical Manufacturing Business (US$ Million), 2021–2026
 Table 87. Boehringer Ingelheim Recent Development
 Table 88. Fareva Holding Company Details
 Table 89. Fareva Holding Business Overview
 Table 90. Fareva Holding Contract Pharmaceutical Manufacturing Product
 Table 91. Fareva Holding Revenue in Contract Pharmaceutical Manufacturing Business (US$ Million), 2021–2026
 Table 92. Fareva Holding Recent Development
 Table 93. AbbVie Company Details
 Table 94. AbbVie Business Overview
 Table 95. AbbVie Contract Pharmaceutical Manufacturing Product
 Table 96. AbbVie Revenue in Contract Pharmaceutical Manufacturing Business (US$ Million), 2021–2026
 Table 97. AbbVie Recent Development
 Table 98. Nipro Corp Company Details
 Table 99. Nipro Corp Business Overview
 Table 100. Nipro Corp Contract Pharmaceutical Manufacturing Product
 Table 101. Nipro Corp Revenue in Contract Pharmaceutical Manufacturing Business (US$ Million), 2021–2026
 Table 102. Nipro Corp Recent Development
 Table 103. Vetter Company Details
 Table 104. Vetter Business Overview
 Table 105. Vetter Contract Pharmaceutical Manufacturing Product
 Table 106. Vetter Revenue in Contract Pharmaceutical Manufacturing Business (US$ Million), 2021–2026
 Table 107. Vetter Recent Development
 Table 108. Sopharma Company Details
 Table 109. Sopharma Business Overview
 Table 110. Sopharma Contract Pharmaceutical Manufacturing Product
 Table 111. Sopharma Revenue in Contract Pharmaceutical Manufacturing Business (US$ Million), 2021–2026
 Table 112. Sopharma Recent Development
 Table 113. DPT Laboratories Company Details
 Table 114. DPT Laboratories Business Overview
 Table 115. DPT Laboratories Contract Pharmaceutical Manufacturing Product
 Table 116. DPT Laboratories Revenue in Contract Pharmaceutical Manufacturing Business (US$ Million), 2021–2026
 Table 117. DPT Laboratories Recent Development
 Table 118. Recipharm Company Details
 Table 119. Recipharm Business Overview
 Table 120. Recipharm Contract Pharmaceutical Manufacturing Product
 Table 121. Recipharm Revenue in Contract Pharmaceutical Manufacturing Business (US$ Million), 2021–2026
 Table 122. Recipharm Recent Development
 Table 123. NextPharma Company Details
 Table 124. NextPharma Business Overview
 Table 125. NextPharma Contract Pharmaceutical Manufacturing Product
 Table 126. NextPharma Revenue in Contract Pharmaceutical Manufacturing Business (US$ Million), 2021–2026
 Table 127. NextPharma Recent Development
 Table 128. Dishman Company Details
 Table 129. Dishman Business Overview
 Table 130. Dishman Contract Pharmaceutical Manufacturing Product
 Table 131. Dishman Revenue in Contract Pharmaceutical Manufacturing Business (US$ Million), 2021–2026
 Table 132. Dishman Recent Development
 Table 133. Aesica Company Details
 Table 134. Aesica Business Overview
 Table 135. Aesica Contract Pharmaceutical Manufacturing Product
 Table 136. Aesica Revenue in Contract Pharmaceutical Manufacturing Business (US$ Million), 2021–2026
 Table 137. Aesica Recent Development
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Contract Pharmaceutical Manufacturing Picture
 Figure 2. Global Contract Pharmaceutical Manufacturing Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Contract Pharmaceutical Manufacturing Market Share by Type: 2025 vs 2032
 Figure 4. Oral Features
 Figure 5. Injectable Features
 Figure 6. API Features
 Figure 7. Other Features
 Figure 8. Global Contract Pharmaceutical Manufacturing Market Size by Application (US$ Million), 2021–2032
 Figure 9. Global Contract Pharmaceutical Manufacturing Market Share by Application: 2025 vs 2032
 Figure 10. Large Enterprise Case Studies
 Figure 11. Small Medium Enterprise Case Studies
 Figure 12. Contract Pharmaceutical Manufacturing Report Years Considered
 Figure 13. Global Contract Pharmaceutical Manufacturing Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 14. Global Contract Pharmaceutical Manufacturing Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Contract Pharmaceutical Manufacturing Market Share by Region: 2025 vs 2032
 Figure 16. Global Contract Pharmaceutical Manufacturing Market Share by Players in 2025
 Figure 17. Global Contract Pharmaceutical Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by Contract Pharmaceutical Manufacturing Revenue in 2025
 Figure 19. North America Contract Pharmaceutical Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. North America Contract Pharmaceutical Manufacturing Market Share by Country (2021–2032)
 Figure 21. United States Contract Pharmaceutical Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Canada Contract Pharmaceutical Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Contract Pharmaceutical Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Contract Pharmaceutical Manufacturing Market Share by Country (2021–2032)
 Figure 25. Germany Contract Pharmaceutical Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. France Contract Pharmaceutical Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. U.K. Contract Pharmaceutical Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Italy Contract Pharmaceutical Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Russia Contract Pharmaceutical Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Ireland Contract Pharmaceutical Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Contract Pharmaceutical Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Contract Pharmaceutical Manufacturing Market Share by Region (2021–2032)
 Figure 33. China Contract Pharmaceutical Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Japan Contract Pharmaceutical Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. South Korea Contract Pharmaceutical Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Southeast Asia Contract Pharmaceutical Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. India Contract Pharmaceutical Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Australia & New Zealand Contract Pharmaceutical Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Contract Pharmaceutical Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Contract Pharmaceutical Manufacturing Market Share by Country (2021–2032)
 Figure 41. Mexico Contract Pharmaceutical Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Brazil Contract Pharmaceutical Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Contract Pharmaceutical Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Contract Pharmaceutical Manufacturing Market Share by Country (2021–2032)
 Figure 45. Israel Contract Pharmaceutical Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Saudi Arabia Contract Pharmaceutical Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. UAE Contract Pharmaceutical Manufacturing Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Catalent Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2021–2026)
 Figure 49. DPx Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2021–2026)
 Figure 50. Lonza Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2021–2026)
 Figure 51. Piramal Healthcare Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2021–2026)
 Figure 52. Aenova Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2021–2026)
 Figure 53. Jubilant Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2021–2026)
 Figure 54. Famar Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2021–2026)
 Figure 55. Boehringer Ingelheim Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2021–2026)
 Figure 56. Fareva Holding Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2021–2026)
 Figure 57. AbbVie Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2021–2026)
 Figure 58. Nipro Corp Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2021–2026)
 Figure 59. Vetter Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2021–2026)
 Figure 60. Sopharma Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2021–2026)
 Figure 61. DPT Laboratories Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2021–2026)
 Figure 62. Recipharm Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2021–2026)
 Figure 63. NextPharma Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2021–2026)
 Figure 64. Dishman Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2021–2026)
 Figure 65. Aesica Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2021–2026)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS